Yasuji Matsuoka

Yokohama National University — Japan

Medicine · Health Sciences

43h-index7.4kcitations119works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(47), Neuroscience and Neuropharmacology Research(23), Neuroinflammation and Neurodegeneration Mechanisms(21), Heme Oxygenase-1 and Carbon Monoxide(12), Cholinesterase and Neurodegenerative Diseases(10)

Publications119 total

Baseline Mismatch Negativity Amplitude Predicts Direction and Magnitude of Ketamine Effect in Healthy Volunteers — A “Disordinal” Effect
2025Open Access
How to Accomplish Key and Communication Compression Over Authentication Channels
Lecture notes in computer science·2025
The hydroxycarboxylic acid receptor <scp>HCA2</scp> is required for the protective effect of ketogenic diet in epilepsy
Pharmacology Research & Perspectives·2024· 2 citedOpen Access
Novel KV7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contraction
Bioorganic & Medicinal Chemistry Letters·2018· 27 citedOpen Access
CCDC 1855751: Experimental Crystal Structure Determination
The Cambridge Structural Database·2018Open Access
RESIDENTS’ STRENGTHS AND INFLUENCING FEATURES IN A SUPER-AGED SOCIAL HOUSING COMMUNITY
Innovation in Aging·2017Open Access
Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor
Antioxidants and Redox Signaling·2015· 187 citedOpen Access
P2–212: Morphometric analysis of the retina in a triple‐transgenic model of Alzheimer's disease
Alzheimer s & Dementia·2013Open Access
Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo
Neuropharmacology·2013· 10 cited
<i>γ</i>-Secretase Pharmacology: What Pharmacology Will Work for Alzheimer's Disease?
International Journal of Alzheimer s Disease·2013· 2 citedOpen Access
Cyclooxygenase‐1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease
Journal of Neurochemistry·2012· 127 citedOpen Access
γ‐Secretase modulators do not induce Aβ‐rebound and accumulation of β‐C‐terminal fragment
Journal of Neurochemistry·2011· 28 cited
Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice
Neurobiology of Aging·2011· 26 citedOpen Access
Pyridine-derived γ-secretase modulators
Bioorganic & Medicinal Chemistry Letters·2011· 29 citedOpen Access
Pyridazine-derived γ-secretase modulators
Bioorganic & Medicinal Chemistry Letters·2011· 18 cited
Triazole-linked reduced amide isosteres: An approach for the fragment-based drug discovery of anti-Alzheimer’s BACE1 inhibitors
Bioorganic & Medicinal Chemistry Letters·2011· 44 citedOpen Access
A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice
PLoS ONE·2011· 72 citedOpen Access
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease
Journal of Neuroinflammation·2010· 20 citedOpen Access
O4‐02‐05: <i>In vivo</i> turnover of tau and APP metabolites in the brains of wild‐type and Tg2576 mice: Greater stability of sAPP in the β‐amyloid‐depositing mice
Alzheimer s & Dementia·2010
O4‐06‐03: Aβ/APP‐dependent tangle modification via WAVE accumulation in Alzheimer's disease
Alzheimer s & Dementia·2010
page 1 of 6Next →

Frequent Co-authors

Yoshihisa Kitamura(16), Karen Duff(11), Yasuyuki Nomura(11), Takashi Taniguchi(10), Takashi Taniguchi(8), Paul Aisen(7), John J. LaFrancois(6), Chiho Hirata‐Fukae(6), Audrey Gray(6), G. William Rebeck(6), Shun Shimohama(6), Mitsuhiro Okazaki(6), Sakura Minami(5), Ikuo Tooyama(5), Mark P. Mattson(4), Kate Gaynor(4), Mariko Saito(4), Jun‐ichi Kakimura(4), Peter J. Gebicke‐Haerter(4), Amanda G. Becker(4)